| 14/11/2017 | |||
 08:30 - 09:00 | Registration & Welcome coffee | ||
| 09:00 - 09:10 | Oligometastatic Colorectal Cancer: Introduction Speaker(s): A. D'Hoore, MD, PhD, University Hospitals Leuven, Belgium | ||
| 09:10 - 09:50 | SESSION I: Imaging in Metastatic Disease Chair(s): J. Decaestecker, MD, AZ Delta, Roeselare-Menen, Belgium Chair(s): E. Van Cutsem, MD, PhD, University Hospitals Leuven, Belgium | ||
| 09:10 - 09:25 | PET Imaging in Metastatic Colorectal Cancer Speaker(s): C. Deroose, MD, PhD, University Hospitals Leuven, Belgium | ||
| 09:25 - 09:40 | Whole-body Diffusion-weighted MRI in Colorectal Cancer Speaker(s): E. Dresen, MD, PhD, University Hospitals Leuven, Belgium | ||
| 09:40 - 09:50 | Q&A and discussion | ||
| 09:50 - 10:15 | SESSION II: Treatment Strategy Chair(s): E. Van Cutsem, MD, PhD, University Hospitals Leuven, Belgium Chair(s): C. Jehaes, MD, Clinique Saint Joseph, Liège, Belgium | ||
| 09:50 - 10:10 | The General Framework: the Toolbox of Locoregional Modalities Integrated in the Treatment Strategy Speaker(s): D. Arnold, MD, PhD, Asklepios Tumorzentrum Hamburg, Germany and Instituto CUF de Oncologia, Lisbon, Portugal | ||
| 10:10 - 10:15 | Q&A and discussion | ||
| 10:15 - 11:25 | SESSION III (part I): Liver Metastasis Chair(s): E. Van Cutsem, MD, PhD, University Hospitals Leuven, Belgium Chair(s): C. Jehaes, MD, Clinique Saint Joseph, Liège, Belgium | ||
| 10:15 - 10:30 | Surgery for the Primary First Speaker(s): Y. Panis, MD, PhD, Hôpital Beaujon, France | ||
| 10:30 - 10:45 | Chemo First for Most Patients Speaker(s): J. Dekervel, MD, PhD, University Hospitals Leuven, Belgium | ||
| 10:45 - 10:55 | Q&A and discussion | ||
| 10:55 - 11:25 | Coffee break and Exhibition | ||
| 11:25 - 12:50 | SESSION III (part II): Liver Metastasis Chair(s): M. D'Hondt, MD, AZ Groeninge, Kortrijk, Belgium Chair(s): V. Lucidi, MD, Hôpital Académique Erasme, Belgium Chair(s): P.J. Cuyle, MD, Imelda Hospital, Bonheiden, Belgium | ||
| 11:25 - 11:50 | Surgical Strategies and Techniques in Liver Limited Metastatic Colorectal Cancer Speaker(s): B. Topal, MD, PhD, University Hospitals Leuven, Belgium | ||
| 11:50 - 12:05 | Efficacy of Local Ablative Therapies Speaker(s): J. Jaekers, MD, University Hospitals Leuven, Belgium | ||
| 12:05 - 12:20 | Strategic Considerations for Chemotherapy in Resectable and Potentially Resectable Liver Metastases Speaker(s): E. Van Cutsem, MD, PhD, University Hospitals Leuven, Belgium | ||
| 12:20 - 12:27 | The Vanished Liver Met Speaker(s): R. Aerts, MD, University Hospitals Leuven, Belgium | ||
| 12:27 - 12:34 | Toxicity of Chemo in Liver Surgery Speaker(s): V. Lucidi, MD, Hôpital Académique Erasme, Belgium | ||
| 12:34 - 12:50 | Q&A and discussion | ||
| 12:50 - 14:00 | Lunch & Exhibition | ||
| 14:00 - 14:25 | Session IV: Lung Metastasis Chair(s): A. Wolthuis, MD, PhD, University Hospitals Leuven, Belgium Chair(s): A. Kartheuser, MD, UC Louvain, Belgium Chair(s): J. Janssens, MD, AZ Turnhout, Belgium | ||
| 14:00 - 14:20 | Lung Metastasectomy: Common Practice, but Little Evidence Speaker(s): D. Van Raemdonck, MD, PhD, University Hospitals Leuven, Belgium | ||
| 14:20 - 14:25 | Q&A and discussion | ||
| 14:25 - 15:20 | SESSION V: Peritoneal Metastasis Chair(s): A. Wolthuis, MD, PhD, University Hospitals Leuven, Belgium Chair(s): A. Kartheuser, MD, UC Louvain, Belgium Chair(s): J. Janssens, MD, AZ Turnhout, Belgium | ||
| 14:25 - 14:40 | How to Define High Risk for Peritoneal Dissemination? Speaker(s): P. J. Tanis, MD, PhD, AMC, The Netherlands | ||
| 14:40 - 14:55 | HIPEC: Indications and Results Speaker(s): A. Wolthuis, MD, PhD, University Hospitals Leuven, Belgium | ||
| 14:55 - 15:05 | Strategy if Inadvertent Finding of Peritoneal Met's Speaker(s): A. D'Hoore, MD, PhD, University Hospitals Leuven, Belgium | ||
| 15:05 - 15:20 | Q&A and discussion | ||
| 15:20 - 15:50 | Coffee break and Exhibition | ||
| 15:50 - 16:25 | Session VI: Future Developments Chair(s): B. Topal, MD, PhD, University Hospitals Leuven, Belgium Chair(s): C. Verslype, MD, PhD, University Hospitals Leuven, Belgium | ||
| 15:50 - 16:05 | The Role of Radiotherapy in Oligometastatic Disease K. Haustermans, MD, PhD, University Hospitals Leuven, Belgium | ||
| 16:05 - 16:15 | Can Radioembolization and Chemoembolization Downstage to Surgery? Speaker(s): G. Maleux, MD, PhD, University Hospitals Leuven, Belgium | ||
| 16:15 - 16:25 | Q&A and discussion | ||
| 16:25 - 16:40 | Session VII: Leuven Multidisciplinary Approach to Oligometastatic Colorectal Cancer | ||
| 16:25 - 16:35 | Wrap up Speaker(s): A. D'Hoore, MD, PhD, University Hospitals Leuven, Belgium Speaker(s): E. Van Cutsem, MD, PhD, University Hospitals Leuven, Belgium | ||
| 16:35 - 16:40 | Closing Speaker(s): A. Wolthuis, MD, PhD, University Hospitals Leuven, Belgium | ||
| 16:40 - 17:40 | Closing drink | ||
